Watson Seeks Co-Promotion Partner For Oxytrol In Primary Care Setting
This article was originally published in The Pink Sheet Daily
Executive Summary
The company is seeking a partner with "strong relationships" with high-volume prescribers of overactive bladder therapies in the primary care market. Watson wants to retain Oxytrol's position in primary care despite the company's intention to shift its marketing focus to specialty care.